Search for: "NASDAQ" Results 721 - 740 of 3,423
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Aug 2021, 7:26 am by Kevin LaCroix
The shares of the combined company began trading on NASDAQ on November 11, 2019. [read post]
30 Jul 2021, 7:58 am by Kristian Soltes
Legal and Regulatory Developments SPOTLIGHT: Why Biden’s Executive Order Is a Green Light for Us Open BankingFinextra – July 28, 2021 On July 9 2021, President Biden didn’t just throw a bone to US open banking, he underwrote the mortgage, laid the welcome mat, and set the table to officially welcome open banking to the neighbourhood. [read post]
28 Jul 2021, 2:48 pm by Iorio Altamirano
Iorio Altamirano LLP is investigating potential claims involving investments in L Bonds offered by GWG Holdings (Nasdaq: GWGH). [read post]
26 Jul 2021, 3:30 am by Liz Dunshee
The deal is getting a lot of press – and this Nasdaq article says it’s just one of 17 IPOs on the ticket for this week. [read post]
19 Jul 2021, 2:45 pm by Kevin LaCroix
The NASDAQ proposal, citing more than two dozen studies explaining the tangible benefits of diverse boardrooms, would require NASDAQ-listed companies to meet board composition requirements or publicly explain why they have failed to do so. [read post]
14 Jul 2021, 2:22 pm by Kevin LaCroix
On July 13, 2021, a plaintiff shareholder filed a securities class action lawsuit against 360 DigiTech, a Chinese company with securities listed on NASDAQ, following news that the company’s app had been removed from major app stores following Chinese investigations of a number of companies’ data security practices. [read post]
12 Jul 2021, 10:36 am by Daily Record Staff
MaxCyte Inc. of Gaithersburg announced the public filing of a registration statement on Form S-1 with the SEC relating to a proposed dual listing of its shares of common stock on the Nasdaq Global Market under the symbol "MXCT. [read post]
11 Jul 2021, 8:50 am by Alan Rosca
In September 2020, Athira Pharma published a Prospectus offering 12,000,000 shares approved for listing on Nasdaq at $17 per share. [read post]
11 Jul 2021, 8:50 am by Alan Rosca
In September 2020, Athira Pharma published a Prospectus offering 12,000,000 shares approved for listing on Nasdaq at $17 per share. [read post]
11 Jul 2021, 8:50 am by Alan Rosca
In September 2020, Athira Pharma published a Prospectus offering 12,000,000 shares approved for listing on Nasdaq at $17 per share. [read post]
6 Jul 2021, 3:15 am by Lynn Jokela
Meanwhile, NASDAQ does not consider directors of Middle Eastern descent as racially or ethnically diverse[3] but ISS does[4]. [read post]
3 Jul 2021, 4:37 am by Rob Robinson
Editor’s Note: Since beginning in November 2001 to track the number of publicly highlighted merger, acquisition, and investment (M&A+I) events in the eDiscovery ecosystem, ComplexDiscovery has recorded 482* M&A+I events. [read post]
2 Jul 2021, 2:15 am by John Jenkins
Last week, Nasdaq filed a proposed amendment to that rule that would tweak the pricing parameters for these new listings. [read post]
1 Jul 2021, 2:33 pm by Iorio Altamirano
  The IPO filing reveals that the company plans to list its share on the Nasdaq stock exchange under the symbol HOOD. [read post]
1 Jul 2021, 2:26 pm by Kevin LaCroix
California’s board diversity legislation and Nasdaq’s board diversity guidelines represent other initiatives as part of this general effort to encourage greater board diversity. [read post]
28 Jun 2021, 3:15 pm by Kevin LaCroix
Between 2010 and 2019, there was an average of about 3,700 companies[11] listed on the NASDAQ and NYSE in any given quarter. [read post]